Archives
-
ORM2–ZG16 Autophagy in Chronic Pancreatitis
2026-09-23
A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of pancreatic fibrosis and connects its activity to ZG16-dependent control of autophagic flux in pancreatic stellate cells. The work combines pancreas-specific AAV manipulation, stellate-cell models, autophagy imaging, and protein-interaction analysis to establish a mechanistic framework for chronic pancreatitis research.
-
Urine Stem Cell Mitochondrial Morphology in Alzheimer’s
2026-09-22
This Neurotherapeutics study developed a deep-learning framework that analyzes mitochondrial morphology in living urine-derived stem cells to distinguish cognitively impaired individuals from cognitively normal controls. Its combination of non-invasive cell collection, fluorescence imaging, and ResNet-18 classification supports mitochondrial morphology as a promising research biomarker, although clinical validation remains necessary.
-
Stat3 and NF-κB in Fyn-Driven Neurodegeneration
2026-09-22
A 2024 Disease Models & Mechanisms study uses a neural-specific zebrafish model of constitutively active Fyn to connect dopaminergic neuron loss with microglial inflammation. Its key contribution is identifying Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a pathway-focused framework for studying neurodegeneration.
-
Cell Counting Kit-8 (CCK-8) Plus Protocol
2026-09-21
Cell Counting Kit-8 (CCK-8) Plus, SKU K2268, provides a rapid WST-8-based readout for viable-cell-associated metabolic activity in proliferation, cytotoxicity, and drug screening workflows. It should be interpreted as a dehydrogenase-linked viability signal within a validated linear range, not as a direct cell count or standalone proof of cell death mechanism.
-
Luminescent ATP Viability Assay for Ferroptosis
2026-09-21
Ferroptosis research increasingly depends on distinguishing pathway activation from the final loss of viable cells. This thought-leadership guide shows how ATP-based luciferase luminescence detection can strengthen translational cytotoxicity workflows while clarifying what the signal can—and cannot—reveal about the STING1–CAV2, mitochondrial zinc, and reactive oxygen species biology described in the anchor study.
-
Dual-Action Inhibitors Rewire p38α Dephosphorylation
2026-09-20
The reference preprint shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also reshape the activation loop to accelerate WIP1-mediated dephosphorylation. Structural and biochemical results introduce kinase-state control as a potential route to improve inhibitor potency and specificity, while also defining important limits for translating purified-protein findings into cellular research.
-
UBE2T–SOCS2–JAK/STAT3 Signaling in PTC
2026-09-19
A February 2026 study identifies UBE2T as a driver of papillary thyroid carcinoma aggressiveness and links its effects to SOCS2 destabilization and JAK/STAT3 activation. The findings provide a mechanistic framework for studying invasion and lymph node metastasis, while also highlighting the need to distinguish growth, viability, and invasion phenotypes in follow-up experiments.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-18
The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid dual-fluorescence readout for separating viable, early apoptotic, late apoptotic, and necrotic cell populations. It is suitable for flow cytometry or fluorescence microscopy in cell viability and cytotoxicity workflows, but it should not be used alone to identify a specific apoptotic signaling mechanism.
-
EdU Imaging Kits (488) for NSCLC Cell-Cycle Studies
2026-09-18
Turn S-phase entry into a clean, image-ready endpoint for treatment-response studies in NSCLC and other proliferating cell models. EdU Imaging Kits (488) combine click-chemistry labeling with nuclear staining, enabling faster proliferation analysis while preserving morphology and antigen-binding sites.
-
Porcupine Inhibition for Severe Sclerosteosis
2026-09-17
Dreyer and colleagues identify PORCN inhibition with LGK974 as a potential pharmacological strategy for sclerosteosis, a severe high-bone-mass disorder caused by loss of functional sclerostin. Their combined cell, mouse, and mechanoadaptation experiments show reduced osteoblast activity and skeletal overgrowth, while also revealing sex-dependent differences in target engagement.
-
Ceruletide as a Mechanistic Pancreatic Fibrosis Tool
2026-09-17
Ceruletide, also known as Caerulein, is more than a pancreatitis inducer: it can function as a controlled secretagogue stressor for connecting pancreatic injury, stellate-cell remodeling, and antifibrotic mechanisms. This article presents an assay strategy grounded in recent MFGE8–ANXA1–SMAD2/3 research.
-
From Mycangia to Mechanism: PCR for Translation
2026-09-16
A thought-leadership perspective on how the study of ambrosia beetle–fungal mutualisms illustrates a broader translational principle: biological discovery becomes actionable only when sampling, molecular confirmation, and functional validation are connected by reproducible workflows. The article examines how 2X Taq PCR Master Mix (with dye) can support routine genotyping, cloning, and sequence-analysis steps while clarifying its mechanistic strengths, limitations, and strategic position.
-
CCK8 Workflows for LNP Cell Viability Studies
2026-09-16
Use CCK8 to distinguish formulation-related cytotoxicity from changes in cellular metabolic activity during mRNA LNP development. This practical workflow connects Cell Counting Kit-8 readouts with biodistribution and transgene-expression questions without treating viability data as a substitute for pharmacokinetic or expression measurements.
-
Cell Counting Kit-8 (CCK-8) Plus Protocol Guide
2026-09-15
Cell Counting Kit-8 (CCK-8) Plus provides a rapid WST-8-based colorimetric readout for estimating viable-cell abundance in proliferation, cytotoxicity, and drug screening workflows. It should be used as a metabolic viability measurement within a validated linear range, not as a direct cell counter or a standalone proof of a specific cell-death mechanism.
-
Primary Antibody Dilution Buffer in CNS Lymphoma
2026-09-15
A translational perspective on how the Primary Antibody Dilution Buffer can support tissue-level validation of SLC2A5-mediated fructose metabolism in primary CNS lymphoma, while keeping assay performance, evidence boundaries, and workflow strategy in view.